Core Viewpoint - MacKenzie Realty Capital, Inc. has successfully closed a $3 million loan agreement to facilitate the purchase of non-traded REIT shares, which is a key part of its investment strategy aimed at enhancing profitability and cash flow [1][2]. Company Overview - MacKenzie Realty Capital, founded in 2013, is a West Coast-focused REIT that aims to invest at least 80% of its total assets in real property and up to 20% in illiquid real estate securities. The portfolio is intended to be split evenly between multifamily properties and boutique class A office spaces [3]. Recent Financial Activities - In 2024, an affiliate of the company purchased 700,000 Class S Shares of Starwood REIT at $17.50 per share, representing a 24% discount to Starwood's estimated net asset value of $22.94. The affiliate invested over $2 million in this transaction [2]. - Last month, the company conducted another tender offer for Starwood REIT at $15.30 per share, acquiring approximately $1 million worth of shares, funded by the new loan agreement [2]. Strategic Importance of Loan - The $3 million loan facility provides the company with the flexibility to continue investing in non-traded REITs, which is a long-standing and profitable business strategy [2].

Core Insights - Babcock & Wilcox Enterprises, Inc. (NYSE: BW) is experiencing a significant recovery in its stock prices, with common shares increasing approximately 455% from their lows in April [1] Group 1: Company Performance - The common shares of Babcock & Wilcox have seen a remarkable rise of about 455% since April [1] - The preferred shares have also shown a strong recovery, although specific percentage changes are not detailed [1] Group 2: Market Context - The equity market is characterized by daily price fluctuations that can lead to substantial wealth creation or destruction over the long term [1] - Pacifica Yield is focused on long-term wealth creation by targeting undervalued high-growth companies, high-dividend stocks, REITs, and green energy firms [1]

Core Viewpoint - A class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. for allegedly providing misleading information regarding the safety and clinical trial protocol of its product RP-A501, leading to inflated stock prices and subsequent investor losses [1][5]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of purchasers of Rocket Pharmaceuticals securities between February 27, 2025, and May 26, 2025 [1]. - The lawsuit claims that Rocket Pharmaceuticals made overwhelmingly positive statements while concealing material adverse facts about the safety of RP-A501, including the risk of Serious Adverse Events (SAEs) [5]. - The company allegedly amended the trial protocol without informing shareholders, which contributed to artificially inflated stock prices [5]. Group 2: Investor Information - Investors who purchased securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by August 11, 2025, to represent the class in the lawsuit [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Trump Media and Technology Group Corp. has filed a final prospectus following the SEC's declaration of effectiveness for its registration statement, which is part of its expansion strategy [2][3]. Group 1: Financial Details - The registration statement registers for resale approximately 56 million shares of equity and 29 million shares underlying convertible notes, resulting from debt and equity agreements that yielded approximately $2.3 billion in total proceeds [3]. - The company has no immediate plans to issue any securities under the shelf registration statement, which is designed to provide greater flexibility for future initiatives [4]. Group 2: Strategic Expansion - Trump Media's CEO, Devin Nunes, emphasized the company's aggressive expansion plans across its social media platform, streaming service, and FinTech brand, aiming to transform Trump Media into a key player in the "Patriot Economy" [5]. - The company operates Truth Social, a platform for free expression, Truth+, a family-friendly streaming service, and is launching Truth.Fi, a financial services brand [7].

Group 1 - NOVAGOLD Resources Inc. will release its 2025 second quarter report before market open on June 25, 2025 [1] - A conference call and video webcast will follow the report release at 8:00 am PT, featuring updates from the Chairman and CEO on recent transactions and strategic implications [2] - The CFO will present a summary of the second quarter financial results during the webcast [2] Group 2 - Questions can be submitted prior to the call via email, and there will be an opportunity for live questions during the webcast [3] - The video webcast will be archived on NOVAGOLD's website for one year, and a transcript will be available for download [4]

Core Points - Bonterra Resources Inc. has increased the size of its brokered private placement due to strong market demand, now targeting gross proceeds of up to approximately $10,500,000 [1][4] - The offering includes three types of units: up to 22,727,272 "hard-dollar" units at $0.22 each, up to 14,583,333 "flow-through" units at C$0.24 each, and up to 6,557,377 "Premium flow-through" units at C$0.305 each [1][3] - The completion of the offering is expected on June 30, 2025, subject to customary conditions and necessary approvals [4] Use of Proceeds - The net proceeds from the offering will be used to fund ongoing operations for the next twelve months [5] - Proceeds from the sale of HD Units will be allocated for general corporate and administrative matters [6] - Gross proceeds from FT Units and Premium FT Units will be used to incur eligible "Canadian exploration expenses" as defined in the Income Tax Act (Canada) [6]

The days of ordering from a human at drive-thrus and by phone are numbered. The rise of artificial intelligence (AI), particularly the emergence of conversational intelligence, combined with businesses' desire for efficiency and cost savings, makes the transition from human to automated processes inevitable. Thanks to AI, machines can "understand" human speech in real time.The change is also being introduced in automobiles. Where previously the vehicle could process "Call John Smith," new AI-powered assista ...

Group 1: Core Company Insights - CoreWeave stock has increased nearly 300% since its IPO in March [1][4] - The company operates in the infrastructure-as-a-service (IaaS) sector, providing access to GPU architectures through a cloud-based model [7][4] - CoreWeave is positioned uniquely in the AI industry, catering to the needs of AI developers by offering a more efficient and less capital-intensive way to access high-performance GPUs [7][5] Group 2: Market Dynamics - The demand for infrastructure services is rising as cloud hyperscalers like Microsoft, Alphabet, Amazon, and Oracle invest in data center build-outs [2] - There is a challenge in matching chip supply with rising demand, giving supply-constrained businesses significant pricing power [6] - The overall AI infrastructure spending, particularly on hardware, is projected to reach trillions over the next five years, which is favorable for CoreWeave [14] Group 3: Investment Considerations - While CoreWeave's stock has shown significant gains, there are concerns that it may have turned into a momentum opportunity, making it less attractive for new investors at current valuations [12][13] - Most of the substantial gains occurred in May, indicating a pronounced valuation expansion [11] - A more prudent investment strategy may involve waiting for a dip to acquire shares at a more reasonable valuation for long-term growth potential [15]

Core Insights - Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls, surpassing Regeneron Pharmaceuticals' previous offer of $256 million in a bankruptcy auction [1][2] - The deal is expected to close soon, pending a court hearing scheduled for June 17 [1] - 23andMe filed for bankruptcy in March due to declining demand and a data breach in 2023 that compromised sensitive customer information [2][6] Company Developments - 23andMe's bankruptcy filing was a result of a significant decline in consumer demand for DNA testing services [2][6] - The company faced legal challenges, with New York and over two dozen other states suing to contest the sale of its customers' private information [3] - TTAM Research Institute, associated with Wojcicki, has committed to upholding 23andMe's existing privacy policies and complying with data protection laws [2] Competitive Landscape - Regeneron Pharmaceuticals initially offered $256 million for 23andMe, which was later outbid by Wojcicki's nonprofit [1][5] - Regeneron expressed willingness to make a new bid but requested a $10 million breakup fee if Wojcicki's bid is accepted [5]

If there was ever a Dow Industrials stock that should be labeled "buy and hold at your own risk," it is Cisco Systems, Inc. (NASDAQ: CSCO ). I can't think of a stockI'm Rob Isbitts, founder of Sungarden Investment Publishing. I run the new investing group Sungarden Investors Club, a community dedicated to navigating the modern investment climate with humility, discipline, and a non-traditional approach to income investing. I've been charting investments since the 1980s, and I spent decades an an investment ...